,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Electrocardiogram abnormal,1,16164848
1,22.0,Acute myocardial infarction,1,16164848
0,22.0,Sudden death,5,16164855
1,22.0,Pain,6,16164855
2,22.0,Nausea,6,16164855
3,22.0,Vomiting,6,16164855
0,22.0,White blood cell count decreased,6,16164927
1,22.0,Death,5,16164927
2,22.0,Decreased immune responsiveness,6,16164927
0,22.0,Bone marrow failure,1,16165024
0,22.0,Liver disorder,2,16165025
0,22.0,Skin ulcer,2,16165038
0,22.0,Pulmonary embolism,5,16165101
1,22.0,Lower respiratory tract infection,5,16165101
0,22.1,Nerve compression,6,16165108
1,22.1,Peripheral coldness,6,16165108
2,22.1,Neutrophil count decreased,6,16165108
3,22.1,Epilepsy,6,16165108
4,22.1,Muscle spasms,6,16165108
0,22.0,Traumatic fracture,3,16165117
1,22.0,Fall,1,16165117
0,22.0,Respiratory depression,6,16165147
1,22.0,Therapeutic product effect decreased,6,16165147
2,22.0,Serotonin syndrome,6,16165147
3,22.0,Convulsive threshold lowered,6,16165147
4,22.0,Confusional state,6,16165147
5,22.0,Hyperhidrosis,6,16165147
6,22.0,Drug interaction,6,16165147
7,22.0,Seizure,6,16165147
8,22.0,Sedation,6,16165147
9,22.0,Delirium,6,16165147
10,22.0,Vomiting,6,16165147
11,22.0,Diarrhoea,6,16165147
12,22.0,Altered state of consciousness,6,16165147
13,22.0,Oedema peripheral,6,16165147
14,22.0,Parasomnia,6,16165147
15,22.0,Abdominal pain upper,6,16165147
16,22.0,Drug intolerance,6,16165147
17,22.0,Nausea,6,16165147
0,22.0,Febrile neutropenia,1,16165151
0,22.0,Cough,6,16165153
1,22.0,Pyrexia,6,16165153
2,22.0,Acute myeloid leukaemia,6,16165153
3,22.0,Malaise,6,16165153
4,22.0,Nausea,6,16165153
0,22.0,Pneumonia aspiration,1,16165165
0,22.0,Steroid withdrawal syndrome,2,16165205
0,22.0,Diarrhoea,1,16165284
0,22.0,Dizziness,2,16165311
1,22.0,Hypoaesthesia,2,16165311
2,22.0,Nausea,2,16165311
3,22.0,Headache,2,16165311
4,22.0,Throat tightness,2,16165311
0,22.0,Acute myeloid leukaemia,1,16165366
0,22.0,Gastric ulcer,1,16165374
1,22.0,Nausea,1,16165374
0,22.0,Hyperuricaemia,6,16165375
0,22.0,Amylase increased,6,16165377
0,22.0,Pancreatitis acute,6,16165381
0,22.0,Blood creatinine increased,6,16165384
0,22.0,Urosepsis,6,16165385
0,22.0,Staphylococcal bacteraemia,6,16165386
0,22.0,Hyperglycaemia,6,16165433
0,22.0,Hepatocellular injury,3,16165457
1,22.0,Sudden death,5,16165457
2,22.0,Renal failure,3,16165457
3,22.0,Skin toxicity,1,16165457
4,22.0,Oedema peripheral,3,16165457
0,22.1,Alanine aminotransferase increased,6,16165465
1,22.1,Malaise,6,16165465
2,22.1,Decreased appetite,1,16165465
3,22.1,Organising pneumonia,3,16165465
4,22.1,Eczema,2,16165465
5,22.1,Acute kidney injury,2,16165465
6,22.1,Hordeolum,6,16165465
7,22.1,Arthralgia,2,16165465
8,22.1,Pyrexia,6,16165465
9,22.1,Malignant neoplasm progression,5,16165465
10,22.1,Aspartate aminotransferase increased,6,16165465
11,22.1,Dermatitis acneiform,3,16165465
12,22.1,Hepatic function abnormal,3,16165465
13,22.1,Constipation,6,16165465
0,22.0,Product dose omission,6,16165608
0,22.0,Neutropenia,6,16165645
1,22.0,Encephalopathy,6,16165645
0,22.0,Interstitial lung disease,5,16165646
0,22.0,Hepatotoxicity,3,16165683
1,22.0,Neutropenia,1,16165683
0,22.0,Febrile neutropenia,6,16165692
0,22.0,Product dose omission,6,16165705
1,22.0,No adverse event,6,16165705
0,22.0,Malignant neoplasm progression,3,16165713
0,22.0,Osteonecrosis,6,16165775
0,22.1,Ejection fraction decreased,3,16165781
0,22.0,Hepatic function abnormal,6,16165792
0,22.0,Thrombocytopenia,2,16165877
1,22.0,Leukopenia,2,16165877
2,22.0,Anaemia,2,16165877
3,22.0,Neutropenia,2,16165877
0,22.0,Syncope,2,16165878
1,22.0,Diarrhoea,2,16165878
2,22.0,Vomiting,2,16165878
3,22.0,Alopecia,2,16165878
4,22.0,Nausea,2,16165878
5,22.0,Decreased appetite,2,16165878
6,22.0,Dizziness,2,16165878
7,22.0,Hypertransaminasaemia,2,16165878
0,22.0,Pancytopenia,2,16165887
1,22.0,Septic shock,1,16165887
0,22.0,Thrombocytopenia,6,16165899
1,22.0,Off label use,6,16165899
2,22.0,Neutropenia,6,16165899
3,22.0,Leukopenia,6,16165899
0,22.0,Vomiting,1,16165901
1,22.0,Head injury,1,16165901
2,22.0,Syncope,1,16165901
0,22.0,Diarrhoea,1,16165912
1,22.0,Underdose,6,16165912
2,22.0,Pyrexia,1,16165912
3,22.0,Haematochezia,1,16165912
0,22.0,Hypothermia,5,16165973
1,22.0,Diarrhoea,5,16165973
2,22.0,Acute kidney injury,5,16165973
3,22.0,Nausea,5,16165973
4,22.0,Asthenia,5,16165973
0,22.0,Lymphoedema,3,16165984
1,22.0,Humerus fracture,1,16165984
2,22.0,Herpes zoster,1,16165984
3,22.0,Oral herpes,1,16165984
4,22.0,Anaemia,1,16165984
0,22.0,Hair disorder,1,16165989
0,22.0,Bladder cancer recurrent,1,16166010
1,22.0,Product supply issue,6,16166010
2,22.0,Product dose omission,6,16166010
0,22.0,Ileus,6,16166044
1,22.0,Intestinal perforation,3,16166044
0,22.0,Diverticulitis,2,16166068
1,22.0,Pain,6,16166068
2,22.0,Fatigue,6,16166068
3,22.0,Constipation,6,16166068
4,22.0,Oxygen saturation decreased,6,16166068
0,22.0,Hot flush,2,16166123
1,22.0,Dry skin,2,16166123
2,22.0,Neutropenia,2,16166123
3,22.0,Neuropathy peripheral,2,16166123
4,22.0,Alopecia,2,16166123
0,22.1,Urosepsis,1,16166124
1,22.1,Palmar erythema,3,16166124
2,22.1,Dyspnoea,1,16166124
3,22.1,Urinary tract infection,1,16166124
4,22.1,Tendonitis,3,16166124
5,22.1,Dysuria,1,16166124
6,22.1,Chest discomfort,1,16166124
7,22.1,Defaecation urgency,3,16166124
8,22.1,Hypersensitivity,1,16166124
9,22.1,Diarrhoea,1,16166124
10,22.1,Malaise,1,16166124
11,22.1,Rash,1,16166124
12,22.1,Cystitis noninfective,1,16166124
13,22.1,Fatigue,1,16166124
14,22.1,Tremor,1,16166124
15,22.1,Erythema,1,16166124
16,22.1,Hypertension,1,16166124
17,22.1,Anaphylactic reaction,1,16166124
18,22.1,Escherichia test positive,3,16166124
19,22.1,Neuropathy peripheral,1,16166124
20,22.1,Mucosal inflammation,1,16166124
0,22.0,Burning sensation,1,16166156
1,22.0,Headache,1,16166156
2,22.0,Infusion related reaction,1,16166156
3,22.0,Chest pain,1,16166156
0,22.0,Chills,1,16166159
1,22.0,Erythema,1,16166159
2,22.0,Throat irritation,1,16166159
3,22.0,Urticaria,1,16166159
4,22.0,Blood pressure increased,1,16166159
0,22.0,Pain,3,16166180
1,22.0,Abdominal discomfort,3,16166180
2,22.0,Pain in extremity,3,16166180
3,22.0,Sinusitis,3,16166180
4,22.0,Muscle spasms,3,16166180
0,22.0,Leukopenia,1,16166202
1,22.0,Neutropenia,1,16166202
0,22.0,Therapeutic response unexpected,6,16166230
1,22.0,Product use in unapproved indication,6,16166230
0,22.0,Diarrhoea,6,16166241
1,22.0,Nausea,6,16166241
0,22.0,Metastases to central nervous system,6,16166365
1,22.0,Diarrhoea,6,16166365
2,22.0,General physical health deterioration,6,16166365
3,22.0,Vomiting,6,16166365
4,22.0,Death,5,16166365
5,22.0,Hyponatraemia,6,16166365
6,22.0,Nausea,6,16166365
7,22.0,Pneumonia,6,16166365
0,22.0,Wrong technique in product usage process,6,16166419
1,22.0,Wrong technique in product usage process,6,16166419
2,22.0,Drug titration error,3,16166419
0,22.0,Fatigue,3,16166541
1,22.0,Dehydration,3,16166541
0,22.0,Hot flush,6,16166606
0,22.0,Bone marrow failure,1,16166664
1,22.0,Nausea,6,16166664
2,22.0,Emphysema,6,16166664
3,22.0,Pelvic fluid collection,6,16166664
4,22.0,Leukopenia,1,16166664
5,22.0,Hypoaesthesia,6,16166664
0,22.1,Diarrhoea,1,16166666
1,22.1,Orthostatic hypotension,1,16166666
2,22.1,Vomiting,1,16166666
3,22.1,Syncope,1,16166666
4,22.1,Amaurosis,1,16166666
0,22.0,Wound haemorrhage,2,16166676
0,22.0,Off label use,6,16166762
1,22.0,Mediastinum neoplasm,2,16166762
2,22.0,Weight decreased,2,16166762
0,22.0,Large intestine perforation,6,16166881
1,22.0,Pyrexia,1,16166881
2,22.0,Colonic abscess,6,16166881
0,22.0,Dizziness,6,16166883
1,22.0,Facial paralysis,6,16166883
0,22.0,Maculopathy,6,16166951
0,22.0,Unintentional medical device removal,6,16166967
1,22.0,Accidental exposure to product,6,16166967
2,22.0,Wrong technique in product usage process,6,16166967
0,22.0,Metastases to bone,6,16166987
1,22.0,Breast cancer metastatic,6,16166987
2,22.0,Malignant neoplasm progression,6,16166987
3,22.0,Metastases to peritoneum,6,16166987
4,22.0,Metastases to liver,6,16166987
5,22.0,Metastases to skin,6,16166987
0,22.0,Product use in unapproved indication,6,16166994
1,22.0,Death,5,16166994
0,22.0,Condition aggravated,5,16166998
0,22.0,Therapy cessation,6,16167001
0,22.0,Blood pressure decreased,6,16167019
0,22.0,Metastases to spine,5,16167020
1,22.0,Epilepsy,5,16167020
2,22.0,Metastases to central nervous system,5,16167020
0,22.0,Hydronephrosis,1,16167030
1,22.0,Malignant neoplasm progression,5,16167030
2,22.0,Musculoskeletal pain,1,16167030
3,22.0,Abdominal pain,1,16167030
4,22.0,Deep vein thrombosis,2,16167030
0,22.1,Hypertension,2,16167032
1,22.1,Metastases to liver,6,16167032
2,22.1,Disease progression,6,16167032
3,22.1,Hepatic necrosis,6,16167032
4,22.1,Gastrointestinal toxicity,3,16167032
5,22.1,Carcinoembryonic antigen increased,2,16167032
6,22.1,Rash pustular,6,16167032
7,22.1,PIK3CA-activated mutation,6,16167032
8,22.1,Carbohydrate antigen 19-9 increased,2,16167032
0,22.0,Blood bilirubin increased,2,16167035
1,22.0,Thrombocytopenia,2,16167035
0,22.0,Decreased appetite,6,16167057
1,22.0,Dyspnoea,6,16167057
2,22.0,Fatigue,6,16167057
3,22.0,Metastases to bone,1,16167057
4,22.0,Metastases to liver,1,16167057
5,22.0,Osteolysis,6,16167057
6,22.0,Right ventricular dysfunction,6,16167057
7,22.0,Oedema peripheral,6,16167057
8,22.0,Metastases to central nervous system,6,16167057
9,22.0,Metastases to central nervous system,6,16167057
10,22.0,Bone lesion,6,16167057
11,22.0,Metastases to nervous system,1,16167057
12,22.0,Pulmonary embolism,6,16167057
13,22.0,Central nervous system lesion,6,16167057
14,22.0,Metastases to lung,1,16167057
15,22.0,Bone lesion,6,16167057
16,22.0,Alopecia,6,16167057
17,22.0,Diarrhoea,6,16167057
0,22.0,Pruritus,6,16167077
1,22.0,Fatigue,6,16167077
2,22.0,Weight decreased,6,16167077
0,22.0,Liver injury,6,16167087
1,22.0,Bone marrow failure,6,16167087
0,22.0,Malignant neoplasm progression,3,16167107
1,22.0,Hyperbilirubinaemia,6,16167107
0,22.0,Metastases to liver,6,16167122
1,22.0,Neutropenic sepsis,6,16167122
2,22.0,Pneumonia,6,16167122
3,22.0,Malignant neoplasm progression,6,16167122
0,22.0,Ovarian enlargement,6,16167127
1,22.0,Renal failure,6,16167127
2,22.0,Liver disorder,6,16167127
3,22.0,Ovarian cyst,6,16167127
0,22.0,Flushing,6,16167219
1,22.0,Hyperpyrexia,1,16167219
0,22.0,Dyspnoea,2,16167239
1,22.0,Pruritus generalised,2,16167239
0,22.0,Respiratory failure,1,16167328
1,22.0,Bronchospasm,1,16167328
0,22.0,Respiratory distress,1,16167345
1,22.0,Nausea,1,16167345
2,22.0,Diarrhoea,1,16167345
0,22.0,Decreased appetite,6,16167356
1,22.0,Wernicke^s encephalopathy,6,16167356
0,22.0,Blood alkaline phosphatase increased,6,16167357
1,22.0,Abdominal hernia,6,16167357
2,22.0,Aspartate aminotransferase increased,6,16167357
3,22.0,Blood glucose increased,6,16167357
4,22.0,Pulmonary embolism,6,16167357
0,22.0,Myocardial infarction,1,16167358
0,22.0,Febrile neutropenia,1,16167379
1,22.0,Pneumonia,1,16167379
0,22.0,Adverse drug reaction,6,16167507
1,22.0,Small intestinal obstruction,1,16167507
2,22.0,Malignant neoplasm progression,6,16167507
3,22.0,Fatigue,6,16167507
4,22.0,Vomiting,6,16167507
5,22.0,Suicidal ideation,6,16167507
6,22.0,Nausea,6,16167507
0,22.0,Leukopenia,1,16167522
0,22.0,Generalised erythema,1,16167547
1,22.0,Hypotension,1,16167547
2,22.0,Ocular hyperaemia,1,16167547
3,22.0,Nausea,1,16167547
4,22.0,Vision blurred,1,16167547
5,22.0,Oxygen saturation decreased,1,16167547
6,22.0,Pruritus generalised,1,16167547
0,22.0,Constipation,1,16167552
1,22.0,Anxiety,1,16167552
2,22.0,Erythema,1,16167552
3,22.0,Diarrhoea,1,16167552
4,22.0,Diarrhoea,1,16167552
5,22.0,Fatigue,1,16167552
6,22.0,Loss of consciousness,1,16167552
0,22.0,Fatigue,6,16167556
1,22.0,Injection site hyperaesthesia,6,16167556
2,22.0,White blood cell count decreased,6,16167556
0,22.0,Death,5,16167579
0,22.0,Osteoma cutis,6,16167591
0,22.0,Interstitial lung disease,5,16167662
0,22.0,Tachyarrhythmia,1,16167685
0,22.0,Gastritis,4,16167690
0,22.0,Neutrophil count decreased,1,16167730
1,22.0,Hepatic function abnormal,1,16167730
0,22.0,Interstitial lung disease,2,16167761
0,22.0,Radiation necrosis,6,16167766
0,22.0,Dysphagia,1,16167777
1,22.0,Malaise,1,16167777
2,22.0,Nausea,1,16167777
0,22.0,Death,5,16167801
0,22.0,Back pain,6,16167833
1,22.0,Pain in extremity,6,16167833
0,22.0,Neuropathy peripheral,6,16167851
0,22.0,Diarrhoea,6,16167890
1,22.0,Asthenia,6,16167890
0,22.0,Malignant neoplasm progression,6,16167969
1,22.0,Pruritus,6,16167969
2,22.0,Diarrhoea,6,16167969
3,22.0,Nausea,6,16167969
4,22.0,Weight decreased,6,16167969
5,22.0,Metastases to lung,6,16167969
6,22.0,Decreased appetite,6,16167969
7,22.0,Cough,6,16167969
8,22.0,Mucosal inflammation,6,16167969
9,22.0,Carbohydrate antigen 15-3 increased,6,16167969
10,22.0,Neutropenia,6,16167969
11,22.0,Rash generalised,6,16167969
12,22.0,Carcinoembryonic antigen increased,6,16167969
0,22.0,Diarrhoea,3,16167975
1,22.0,Insomnia,3,16167975
2,22.0,Urinary tract infection,3,16167975
0,22.0,Madarosis,3,16168105
1,22.0,Hair texture abnormal,3,16168105
2,22.0,Hair colour changes,3,16168105
3,22.0,Hair disorder,3,16168105
4,22.0,Alopecia,3,16168105
0,22.0,Hair disorder,3,16168124
1,22.0,Hair colour changes,3,16168124
2,22.0,Alopecia,3,16168124
3,22.0,Hair texture abnormal,3,16168124
0,22.0,Hair disorder,3,16168144
1,22.0,Madarosis,3,16168144
2,22.0,Alopecia,3,16168144
3,22.0,Hair colour changes,3,16168144
4,22.0,Hair texture abnormal,3,16168144
0,22.0,Alopecia,3,16168146
1,22.0,Hair texture abnormal,3,16168146
2,22.0,Hair colour changes,3,16168146
3,22.0,Hair disorder,3,16168146
0,22.0,Infection,6,16168151
0,22.0,Fatigue,6,16168200
0,22.0,Therapy cessation,3,16168250
1,22.0,Malignant neoplasm progression,3,16168250
0,22.0,Diarrhoea,6,16168256
1,22.0,Tumour marker increased,6,16168256
2,22.0,Abdominal pain upper,6,16168256
3,22.0,Fatigue,6,16168256
4,22.0,Sleep disorder,6,16168256
0,22.0,Retinal haemorrhage,6,16168273
1,22.0,Rash,6,16168273
2,22.0,Pain in extremity,6,16168273
3,22.0,Diarrhoea,6,16168273
4,22.0,Paronychia,6,16168273
5,22.0,Hypersensitivity,6,16168273
6,22.0,Retching,6,16168273
7,22.0,Tremor,6,16168273
0,22.0,Neutropenia,,16168283
0,22.0,Neutropenia,,16168288
0,22.0,Death,5,16168312
0,22.0,Death,5,16168318
0,22.0,Death,,16168319
0,22.0,Death,5,16168327
1,22.0,Inappropriate schedule of product administration,6,16168327
0,22.0,Death,5,16168330
1,22.0,Inappropriate schedule of product administration,6,16168330
0,22.0,Prostate cancer metastatic,5,16168336
1,22.0,Malignant neoplasm progression,5,16168336
0,22.0,Death,5,16168338
1,22.0,Inappropriate schedule of product administration,6,16168338
0,22.0,Cellulitis,2,16168340
0,22.0,Bone marrow failure,1,16168360
1,22.0,Granulocytopenia,2,16168360
2,22.0,Bone marrow failure,2,16168360
0,22.1,Weight decreased,3,16168368
1,22.1,Dehydration,3,16168368
2,22.1,Decreased appetite,3,16168368
3,22.1,Rash,3,16168368
4,22.1,Skin disorder,1,16168368
5,22.1,Diarrhoea,2,16168368
6,22.1,Fatigue,1,16168368
0,22.1,Muscle spasms,6,16168431
1,22.1,Renal failure,6,16168431
2,22.1,Blood potassium decreased,3,16168431
3,22.1,Stomatitis,3,16168431
4,22.1,Nausea,6,16168431
5,22.1,Decreased appetite,6,16168431
6,22.1,Peripheral swelling,6,16168431
7,22.1,Fatigue,3,16168431
8,22.1,Hypersomnia,3,16168431
9,22.1,Asthenia,6,16168431
10,22.1,Malaise,6,16168431
11,22.1,Blood pressure increased,3,16168431
12,22.1,Pain,3,16168431
13,22.1,Cardiac failure congestive,6,16168431
14,22.1,Dehydration,3,16168431
0,22.0,Disease progression,6,16168454
0,22.0,Hyperhidrosis,,16168489
1,22.0,Dyspnoea,,16168489
0,22.0,Hospice care,,16168514
0,22.0,Malignant neoplasm progression,5,16168527
1,22.0,Rash,6,16168527
0,22.0,Alopecia,3,16168547
1,22.0,Hair texture abnormal,3,16168547
2,22.0,Hair colour changes,3,16168547
3,22.0,Madarosis,3,16168547
4,22.0,Hair disorder,3,16168547
0,22.0,Interstitial lung disease,,16168575
0,22.0,Therapy cessation,,16168616
1,22.0,Vomiting,,16168616
2,22.0,Loss of consciousness,,16168616
0,22.0,Death,,16168621
0,22.0,Pneumonia,6,16168663
0,22.0,Colon neoplasm,6,16168666
0,22.1,Treatment failure,6,16168692
1,22.1,Prostatic specific antigen increased,6,16168692
2,22.1,Malignant neoplasm progression,6,16168692
0,22.0,Thyroid disorder,6,16168730
1,22.0,Myopathy,2,16168730
2,22.0,Liver disorder,6,16168730
0,22.1,Hair texture abnormal,3,16168737
1,22.1,Alopecia,3,16168737
2,22.1,Hair disorder,3,16168737
3,22.1,Madarosis,3,16168737
4,22.1,Hair colour changes,3,16168737
0,22.0,Vomiting,,16168807
1,22.0,Neutropenia,,16168807
2,22.0,Therapy cessation,,16168807
3,22.0,Nausea,,16168807
0,22.0,Radiotherapy,6,16168853
0,22.0,Blood creatinine increased,1,16168964
0,22.0,Pruritus generalised,2,16168983
1,22.0,Dyspnoea,2,16168983
0,22.0,Death,5,16168985
1,22.0,Off label use,6,16168985
2,22.0,Intentional product use issue,6,16168985
0,22.0,Breast cancer metastatic,6,16169025
1,22.0,Metastases to bone,6,16169025
2,22.0,Metastases to liver,6,16169025
3,22.0,Malignant neoplasm progression,6,16169025
4,22.0,Metastases to peritoneum,6,16169025
5,22.0,Metastases to skin,6,16169025
0,22.0,Marasmus,5,16169030
1,22.0,Cardiac failure acute,5,16169030
0,22.0,Neutropenia,2,16169141
0,22.0,Gastrointestinal disorder,2,16169164
1,22.0,Gastrointestinal motility disorder,3,16169164
2,22.0,Urticaria,1,16169164
3,22.0,Hypertension,2,16169164
4,22.0,Amenorrhoea,1,16169164
5,22.0,Hyperglycaemia,3,16169164
6,22.0,Decreased appetite,2,16169164
7,22.0,Skin discolouration,1,16169164
8,22.0,Alopecia,1,16169164
9,22.0,Throat irritation,,16169164
10,22.0,Induration,1,16169164
11,22.0,Gastrointestinal pain,3,16169164
12,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16169164
13,22.0,Fatigue,3,16169164
0,22.0,Cardiac failure,1,16169170
0,22.0,Hot flush,6,16169179
1,22.0,Rash,6,16169179
0,22.0,Terminal state,6,16169201
0,22.0,Polyarthritis,6,16169208
0,22.0,Death,5,16169217
0,22.0,Death,5,16169228
0,22.0,Death,5,16169229
0,22.0,Death,5,16169238
0,22.0,Leukopenia,1,16169251
0,22.0,Hepatotoxicity,2,16169257
1,22.0,Proteinuria,2,16169257
2,22.0,Haematuria,2,16169257
0,22.0,Death,5,16169303
0,22.0,Hair texture abnormal,3,16169312
1,22.0,Madarosis,3,16169312
2,22.0,Alopecia,3,16169312
3,22.0,Hair colour changes,3,16169312
4,22.0,Hair disorder,3,16169312
0,22.0,Stoma site haemorrhage,1,16169318
0,22.0,Death,5,16169325
0,22.0,Staring,1,16169348
1,22.0,Infusion related reaction,1,16169348
2,22.0,Erythema,1,16169348
0,22.0,Death,5,16169351
0,22.0,Device issue,,16169352
1,22.0,Diabetes mellitus inadequate control,,16169352
2,22.0,Incorrect route of product administration,,16169352
3,22.0,Neuropathy peripheral,,16169352
0,22.0,Hepatotoxicity,1,16169429
0,22.0,Disease progression,1,16169434
1,22.0,Oedema peripheral,1,16169434
0,22.0,Death,5,16169439
0,22.0,Colon cancer,6,16169642
1,22.0,Bile duct stenosis,1,16169642
0,22.0,Platelet count decreased,6,16169660
1,22.0,Febrile neutropenia,2,16169660
2,22.0,Hepatic function abnormal,6,16169660
0,22.0,Acute myeloid leukaemia,3,16169692
0,22.0,Pulmonary haemorrhage,6,16169705
0,22.0,Malignant neoplasm progression,5,16169738
1,22.0,Trousseau^s syndrome,6,16169738
2,22.0,Embolic cerebral infarction,4,16169738
0,22.0,Back pain,1,16169900
0,22.0,Fatigue,6,16170016
1,22.0,Enterocolitis haemorrhagic,6,16170016
2,22.0,Neoplasm progression,6,16170016
0,22.0,Anaemia,6,16170022
1,22.0,Dyspnoea,6,16170022
2,22.0,Death,5,16170022
0,22.0,Interstitial lung disease,1,16170027
0,22.0,Hepatitis,4,16170075
0,22.0,Feeding disorder,6,16170082
1,22.0,Stomatitis,6,16170082
2,22.0,Loss of personal independence in daily activities,6,16170082
3,22.0,Oral disorder,6,16170082
4,22.0,Neoplasm progression,6,16170082
5,22.0,Renal failure,6,16170082
6,22.0,Gait inability,6,16170082
7,22.0,Blood pressure decreased,6,16170082
8,22.0,Pain,6,16170082
9,22.0,Aphasia,6,16170082
10,22.0,Asthenia,6,16170082
0,22.0,Neoplasm progression,6,16170084
0,22.0,Bronchitis,4,16170085
0,22.0,Breast cancer metastatic,5,16170086
1,22.0,Malignant neoplasm progression,5,16170086
2,22.0,Gait disturbance,6,16170086
3,22.0,Decreased appetite,6,16170086
4,22.0,Speech disorder,6,16170086
5,22.0,Bone lesion,6,16170086
6,22.0,Dysstasia,6,16170086
7,22.0,Metastases to bone,6,16170086
0,22.0,Neoplasm progression,1,16170098
0,22.1,Headache,6,16170110
1,22.1,Upper respiratory tract infection,6,16170110
2,22.1,Bone pain,6,16170110
3,22.1,Paraesthesia,6,16170110
4,22.1,Product dose omission,6,16170110
0,22.0,Febrile neutropenia,1,16170145
1,22.0,Mental status changes,1,16170145
2,22.0,Lethargy,1,16170145
0,22.0,Product dose omission,6,16170161
1,22.0,No adverse event,6,16170161
0,22.0,Pain,,16170177
1,22.0,Hormone-refractory prostate cancer,,16170177
2,22.0,Prostatic specific antigen increased,,16170177
0,22.0,Decreased appetite,5,16170188
1,22.0,Anal fistula,5,16170188
2,22.0,Ileus,5,16170188
3,22.0,Death,5,16170188
4,22.0,Dermatitis acneiform,5,16170188
5,22.0,Weight decreased,5,16170188
6,22.0,Metastases to lymph nodes,5,16170188
7,22.0,Neuropathy peripheral,5,16170188
8,22.0,Metastases to pelvis,5,16170188
9,22.0,Metastases to peritoneum,5,16170188
0,22.0,Joint swelling,2,16170203
1,22.0,Peripheral swelling,2,16170203
2,22.0,Cartilage injury,2,16170203
3,22.0,Chills,2,16170203
4,22.0,Osteoarthritis,2,16170203
5,22.0,Arthralgia,2,16170203
6,22.0,Osteonecrosis,2,16170203
7,22.0,Vision blurred,2,16170203
0,22.0,Off label use,,16170221
1,22.0,Blood bilirubin increased,,16170221
0,22.1,Candida test positive,6,16170229
1,22.1,Stevens-Johnson syndrome,2,16170229
0,22.0,Chills,1,16170252
1,22.0,Agranulocytosis,1,16170252
2,22.0,Diarrhoea,1,16170252
3,22.0,Pyrexia,1,16170252
4,22.0,Folliculitis,1,16170252
5,22.0,Abdominal pain,1,16170252
0,22.0,Fatigue,6,16170280
1,22.0,Diarrhoea,2,16170280
2,22.0,Alopecia,6,16170280
3,22.0,Asthenia,6,16170280
4,22.0,Ovarian cancer,6,16170280
5,22.0,Death,5,16170280
0,22.0,Chest pain,2,16170312
1,22.0,Myocardial ischaemia,2,16170312
0,22.1,Cystoid macular oedema,1,16170384
0,22.0,Haemorrhage intracranial,6,16170446
1,22.0,Telangiectasia,6,16170446
2,22.0,Thrombocytopenia,6,16170446
0,22.0,Cognitive disorder,6,16170448
0,22.0,Autoimmune disorder,6,16170449
0,22.0,Neoplasm recurrence,6,16170463
0,22.1,Hair disorder,3,16170465
1,22.1,Alopecia,3,16170465
2,22.1,Madarosis,3,16170465
3,22.1,Hair texture abnormal,3,16170465
4,22.1,Hair colour changes,3,16170465
0,22.0,Cholelithiasis,6,16170553
1,22.0,Blood lactate dehydrogenase increased,6,16170553
2,22.0,Tumour marker increased,1,16170553
3,22.0,Aspartate aminotransferase increased,1,16170553
4,22.0,Alanine aminotransferase increased,1,16170553
5,22.0,Gallbladder enlargement,6,16170553
0,22.0,Disease progression,6,16170562
0,22.0,Venous thrombosis limb,6,16170568
0,22.0,Brachiocephalic vein thrombosis,6,16170569
0,22.0,Metastases to bone,6,16170624
1,22.0,Carbohydrate antigen 15-3 increased,6,16170624
0,22.0,Renal failure,3,16170688
1,22.0,Tubulointerstitial nephritis,3,16170688
2,22.0,Chronic kidney disease,3,16170688
0,22.0,Infection,5,16170704
0,22.0,Infection,5,16170705
0,22.0,Infection,5,16170706
0,22.0,Infection,5,16170707
0,22.0,Infection,5,16170708
0,22.0,Infection,5,16170723
0,22.0,White blood cell count decreased,6,16170726
1,22.0,Back disorder,6,16170726
2,22.0,Red blood cell count decreased,6,16170726
3,22.0,Fatigue,6,16170726
4,22.0,Pain,6,16170726
0,22.0,Impaired healing,3,16170733
1,22.0,Pneumothorax,6,16170733
2,22.0,Metastases to lung,6,16170733
0,22.0,Vomiting,1,16170771
1,22.0,Drug interaction,6,16170771
2,22.0,Ileus,1,16170771
3,22.0,Nausea,1,16170771
4,22.0,Constipation,1,16170771
0,22.0,Hyperhidrosis,3,16170791
1,22.0,Weight decreased,6,16170791
2,22.0,Invasive ductal breast carcinoma,3,16170791
3,22.0,Sepsis,6,16170791
4,22.0,Cognitive disorder,3,16170791
5,22.0,Bone density decreased,6,16170791
6,22.0,Large intestine perforation,6,16170791
7,22.0,Middle insomnia,3,16170791
8,22.0,Postoperative wound infection,2,16170791
9,22.0,Weight increased,6,16170791
10,22.0,Malaise,3,16170791
11,22.0,Constipation,6,16170791
12,22.0,Product preparation error,6,16170791
13,22.0,Breast cancer,6,16170791
14,22.0,Nausea,3,16170791
0,22.0,Bone disorder,6,16170812
1,22.0,Osteonecrosis of jaw,6,16170812
2,22.0,Impaired healing,6,16170812
0,22.0,Physical deconditioning,,16170827
1,22.0,Thrombocytopenia,3,16170827
0,22.0,Drug interaction,6,16170882
1,22.0,Clostridium difficile colitis,1,16170882
2,22.0,Agranulocytosis,1,16170882
0,22.0,Madarosis,3,16170893
1,22.0,Hair texture abnormal,3,16170893
2,22.0,Alopecia,3,16170893
3,22.0,Hair colour changes,3,16170893
0,22.0,Fatigue,6,16170894
1,22.0,Dry skin,6,16170894
0,22.0,Neoplasm progression,6,16170895
1,22.0,Off label use,6,16170895
2,22.0,Product use issue,6,16170895
0,22.0,Pleural effusion,3,16170898
1,22.0,Metastases to peritoneum,3,16170898
0,22.0,Dyspnoea,2,16170948
1,22.0,Pruritus generalised,2,16170948
0,22.0,Neoplasm progression,6,16170952
0,22.0,Large intestine perforation,1,16170990
0,22.1,Sepsis,6,16171027
1,22.1,Neoplasm progression,6,16171027
2,22.1,Fall,6,16171027
3,22.1,Humerus fracture,3,16171027
0,22.0,Acute kidney injury,3,16171029
1,22.0,Dizziness,3,16171029
2,22.0,Fall,3,16171029
3,22.0,Vomiting,3,16171029
4,22.0,Polyneuropathy,3,16171029
5,22.0,Urinary tract infection,3,16171029
6,22.0,Bone pain,3,16171029
7,22.0,Urosepsis,3,16171029
8,22.0,Cardiac failure,6,16171029
9,22.0,Dyspnoea exertional,3,16171029
0,22.0,Sudden death,5,16171069
0,22.0,Neoplasm progression,6,16171075
0,22.0,Arrhythmia,5,16171076
0,22.0,Intestinal perforation,5,16171077
0,22.0,Weight decreased,6,16171109
1,22.0,Diarrhoea,6,16171109
2,22.0,Gastroenteritis viral,6,16171109
3,22.0,Gastroenteritis viral,1,16171109
0,22.0,Supraventricular tachycardia,1,16171119
0,22.0,Neutropenia,1,16171189
0,22.0,Neoplasm progression,6,16171198
0,22.0,Laboratory test abnormal,6,16171201
1,22.0,Laboratory test abnormal,6,16171201
2,22.0,Blood test abnormal,6,16171201
0,22.0,Neutrophil count decreased,3,16171228
0,22.0,Alopecia,2,16171229
0,22.0,Psychological trauma,6,16171238
1,22.0,Alopecia,3,16171238
0,22.0,Alopecia,3,16171243
1,22.0,Psychological trauma,6,16171243
0,22.0,Death,5,16171263
0,22.0,Vitreous detachment,3,16171271
0,22.0,Erythema,3,16171324
0,22.0,Product quality issue,1,16171333
1,22.0,Application site erythema,3,16171333
0,22.0,Application site acne,3,16171334
1,22.0,Application site exfoliation,3,16171334
2,22.0,Application site reaction,1,16171334
3,22.0,Papule,3,16171334
4,22.0,Therapeutic product effect delayed,1,16171334
5,22.0,Erythema,3,16171334
6,22.0,Application site papules,3,16171334
7,22.0,Application site inflammation,3,16171334
8,22.0,Application site discomfort,3,16171334
9,22.0,Application site erythema,3,16171334
10,22.0,Infection,6,16171334
11,22.0,Application site swelling,3,16171334
0,22.0,Pruritus,6,16171351
0,22.0,Breast cancer female,6,16171358
1,22.0,Malignant neoplasm progression,6,16171358
0,22.1,Eye pruritus,6,16171377
1,22.1,Nephrolithiasis,1,16171377
2,22.1,Malaise,6,16171377
3,22.1,Ill-defined disorder,6,16171377
4,22.1,Rhinorrhoea,6,16171377
5,22.1,Nephrolithiasis,6,16171377
6,22.1,Paranasal sinus discomfort,1,16171377
7,22.1,Herpes zoster,1,16171377
8,22.1,Hernia,6,16171377
9,22.1,Therapy partial responder,6,16171377
10,22.1,Metastases to liver,6,16171377
11,22.1,Carbohydrate antigen 125 increased,3,16171377
12,22.1,Laboratory test abnormal,6,16171377
13,22.1,Respiratory symptom,1,16171377
14,22.1,Ear congestion,1,16171377
15,22.1,Chest discomfort,1,16171377
16,22.1,Fatigue,6,16171377
17,22.1,Dyspepsia,6,16171377
0,22.0,Sinus tachycardia,1,16171383
0,22.0,Ileus,1,16171384
0,22.0,Cardiac failure,3,16171386
0,22.0,Pseudomonas bronchitis,1,16171490
1,22.0,Pneumonia influenzal,1,16171490
0,22.0,Cerebral haemorrhage,5,16171502
0,22.0,Arthritis,6,16171570
1,22.0,Thyroid disorder,6,16171570
2,22.0,Weight increased,6,16171570
0,22.0,Polyp,6,16171640
1,22.0,Product availability issue,6,16171640
2,22.0,Product dose omission,6,16171640
0,22.0,Musculoskeletal pain,3,16171658
1,22.0,Taste disorder,3,16171658
2,22.0,Arthralgia,3,16171658
3,22.0,Pain in extremity,1,16171658
4,22.0,Cough,3,16171658
5,22.0,Oropharyngeal pain,1,16171658
6,22.0,Pancreatitis,3,16171658
7,22.0,Myalgia,1,16171658
8,22.0,Diarrhoea,3,16171658
9,22.0,Malignant neoplasm progression,3,16171658
10,22.0,Joint stiffness,3,16171658
11,22.0,Blood pressure increased,2,16171658
12,22.0,Decreased appetite,3,16171658
13,22.0,Weight decreased,3,16171658
14,22.0,Speech disorder,3,16171658
15,22.0,Asthenia,3,16171658
16,22.0,Pruritus,3,16171658
0,22.0,Death,5,16171712
0,22.0,Diarrhoea,3,16171715
1,22.0,Pneumonia,3,16171715
2,22.0,Sepsis,3,16171715
0,22.0,Drug-induced liver injury,6,16171722
0,22.0,Product use in unapproved indication,6,16171763
1,22.0,Adverse event,6,16171763
2,22.0,Inappropriate schedule of product administration,6,16171763
3,22.0,Ascites,6,16171763
0,22.0,Telangiectasia,6,16171775
1,22.0,Haemorrhage intracranial,6,16171775
2,22.0,Thrombocytopenia,6,16171775
0,22.1,Adverse event,3,16171799
1,22.1,Weight decreased,3,16171799
2,22.1,Fatigue,3,16171799
3,22.1,Hypothyroidism,2,16171799
4,22.1,Nausea,1,16171799
5,22.1,Dyspnoea,3,16171799
6,22.1,Decreased appetite,3,16171799
7,22.1,Peripheral swelling,1,16171799
8,22.1,Depressed mood,2,16171799
9,22.1,Vomiting,1,16171799
10,22.1,Pulmonary oedema,1,16171799
0,22.0,Dyspnoea,1,16171802
1,22.0,Rash,1,16171802
2,22.0,Swollen tongue,1,16171802
3,22.0,Swelling face,1,16171802
4,22.0,Flushing,1,16171802
5,22.0,Eye swelling,1,16171802
6,22.0,Throat tightness,1,16171802
7,22.0,Pruritus,1,16171802
8,22.0,Paraesthesia oral,1,16171802
9,22.0,Cough,1,16171802
10,22.0,Oropharyngeal swelling,1,16171802
11,22.0,Throat irritation,1,16171802
12,22.0,Angioedema,1,16171802
13,22.0,Anaphylactic reaction,1,16171802
0,22.0,Lung infection,5,16171841
0,22.0,Depressed mood,3,16171846
1,22.0,Product complaint,6,16171846
0,22.0,Death,5,16171857
1,22.0,Asthenia,6,16171857
2,22.0,Malaise,6,16171857
0,22.0,Malaise,6,16171901
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16171901
2,22.0,Rash,2,16171901
0,22.0,Respiratory failure,5,16171987
1,22.0,Cardio-respiratory arrest,5,16171987
2,22.0,Overdose,5,16171987
3,22.0,Coma,5,16171987
0,22.0,Sepsis,6,16172028
1,22.0,Fatigue,1,16172028
0,22.0,Pulmonary embolism,2,16172052
1,22.0,Cor pulmonale acute,2,16172052
2,22.0,Cardiorenal syndrome,2,16172052
0,22.0,Pain,6,16172120
1,22.0,Product dose omission,6,16172120
0,22.0,Enterocolitis haemorrhagic,2,16172164
0,22.0,Diarrhoea,6,16172176
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16172176
2,22.0,Rash,6,16172176
3,22.0,Karnofsky scale worsened,6,16172176
4,22.0,Bone marrow failure,6,16172176
0,22.0,Febrile neutropenia,1,16172202
0,22.0,Diarrhoea,6,16172244
1,22.0,Pulmonary embolism,6,16172244
0,22.0,Death,5,16172270
0,22.0,Posterior reversible encephalopathy syndrome,2,16172295
0,22.0,Blood magnesium decreased,1,16172350
1,22.0,Malaise,1,16172350
2,22.0,Body temperature decreased,1,16172350
0,22.0,Musculoskeletal pain,6,16172368
1,22.0,Death,5,16172368
0,22.0,Diarrhoea,1,16172381
1,22.0,Pyrexia,1,16172381
2,22.0,Chills,1,16172381
3,22.0,Folliculitis,1,16172381
4,22.0,Agranulocytosis,1,16172381
5,22.0,Abdominal pain,1,16172381
0,22.0,Eosinophilic pneumonia,3,16172393
0,22.0,Gastric ulcer haemorrhage,6,16172398
1,22.0,Toxic epidermal necrolysis,2,16172398
2,22.0,Urinary tract infection,6,16172398
3,22.0,Malignant neoplasm progression,5,16172398
0,22.0,Malignant neoplasm progression,6,16172440
0,22.0,Deafness,3,16172473
0,22.0,Death,5,16172478
0,22.1,Fatigue,1,16172504
1,22.1,Osteonecrosis of jaw,6,16172504
2,22.1,Neutropenia,6,16172504
3,22.1,Hypertension,6,16172504
4,22.1,Abdominal pain,6,16172504
5,22.1,Pain in jaw,6,16172504
6,22.1,Clostridium difficile colitis,6,16172504
7,22.1,Diarrhoea,6,16172504
8,22.1,Periodontal disease,6,16172504
9,22.1,Neoplasm progression,6,16172504
10,22.1,Decreased appetite,1,16172504
11,22.1,Drug ineffective,6,16172504
0,22.1,Depression,6,16172535
1,22.1,Retching,6,16172535
2,22.1,Vomiting,3,16172535
3,22.1,Disturbance in attention,6,16172535
4,22.1,Confusional state,6,16172535
5,22.1,Haemoglobin decreased,3,16172535
6,22.1,Diarrhoea,6,16172535
7,22.1,Diarrhoea,6,16172535
8,22.1,Lymphadenopathy,3,16172535
9,22.1,Asthenia,6,16172535
10,22.1,Fatigue,3,16172535
11,22.1,Balance disorder,3,16172535
12,22.1,Hot flush,3,16172535
13,22.1,Blood pressure increased,3,16172535
14,22.1,Gait disturbance,3,16172535
15,22.1,Insomnia,3,16172535
16,22.1,Memory impairment,6,16172535
17,22.1,Product dose omission,6,16172535
18,22.1,Anxiety,6,16172535
19,22.1,Haemoglobin abnormal,3,16172535
20,22.1,Dyspnoea,3,16172535
21,22.1,Diarrhoea,3,16172535
22,22.1,Bowel movement irregularity,3,16172535
0,22.0,Device related infection,5,16172550
1,22.0,Fungaemia,5,16172550
2,22.0,Septic shock,5,16172550
3,22.0,Pyrexia,5,16172550
0,22.0,Hypertension,1,16172585
1,22.0,Hypersensitivity,2,16172585
2,22.0,Hyperhidrosis,1,16172585
3,22.0,Erythema,1,16172585
4,22.0,Nausea,1,16172585
5,22.0,Hypotension,1,16172585
0,22.0,Asthenia,6,16172609
1,22.0,Fatigue,2,16172609
2,22.0,Constipation,1,16172609
3,22.0,Pyrexia,6,16172609
4,22.0,Abdominal pain,6,16172609
5,22.0,Epistaxis,6,16172609
6,22.0,Condition aggravated,3,16172609
7,22.0,Headache,6,16172609
8,22.0,White blood cell count decreased,2,16172609
9,22.0,Pain,6,16172609
10,22.0,Alopecia,3,16172609
11,22.0,Dyspnoea,6,16172609
0,22.0,Stomatitis,2,16172641
1,22.0,Dermatitis acneiform,3,16172641
0,22.0,Anaemia,6,16172677
1,22.0,Sudden death,5,16172677
0,22.0,Cholecystitis chronic,6,16172701
0,22.0,Ill-defined disorder,6,16172719
0,22.1,Haematoma,1,16172742
1,22.1,Arthralgia,2,16172742
2,22.1,General physical health deterioration,1,16172742
3,22.1,Urinary tract infection,1,16172742
4,22.1,Fatigue,3,16172742
5,22.1,Fall,2,16172742
6,22.1,Second primary malignancy,3,16172742
7,22.1,Visual impairment,6,16172742
8,22.1,Thrombocytopenia,1,16172742
9,22.1,Meningioma,3,16172742
10,22.1,Neutropenia,1,16172742
11,22.1,Musculoskeletal pain,2,16172742
12,22.1,Asthenia,1,16172742
13,22.1,Epistaxis,1,16172742
14,22.1,Granulocyte count decreased,6,16172742
15,22.1,Dyspepsia,1,16172742
16,22.1,Transient ischaemic attack,1,16172742
17,22.1,Hypertensive crisis,2,16172742
18,22.1,Leukopenia,1,16172742
0,22.0,Liver disorder,1,16172770
0,22.0,Alopecia,6,16172779
1,22.0,Bone marrow failure,6,16172779
2,22.0,Gastrointestinal disorder,6,16172779
0,22.0,Abdominal distension,1,16172829
1,22.0,Sepsis,1,16172829
2,22.0,Hypotension,1,16172829
0,22.0,Osteonecrosis of jaw,3,16172880
0,22.1,Hypokalaemia,1,16172909
1,22.1,Urinary tract infection,1,16172909
0,22.0,Fatigue,6,16172954
1,22.0,Decreased appetite,6,16172954
2,22.0,Pain,6,16172954
0,22.0,Madarosis,3,16172956
1,22.0,Hair texture abnormal,3,16172956
2,22.0,Hair disorder,3,16172956
3,22.0,Hair colour changes,3,16172956
4,22.0,Alopecia,3,16172956
0,22.0,Alopecia,3,16172969
1,22.0,Hair colour changes,3,16172969
2,22.0,Hair texture abnormal,3,16172969
3,22.0,Madarosis,3,16172969
4,22.0,Hair disorder,3,16172969
0,22.0,Alopecia,3,16172978
1,22.0,Hair colour changes,3,16172978
2,22.0,Madarosis,3,16172978
3,22.0,Hair texture abnormal,3,16172978
4,22.0,Hair disorder,3,16172978
0,22.0,Product administration error,6,16172980
1,22.0,Nausea,6,16172980
2,22.0,Appetite disorder,6,16172980
0,22.0,Alopecia,3,16173023
1,22.0,Hair colour changes,3,16173023
2,22.0,Hair texture abnormal,3,16173023
3,22.0,Madarosis,3,16173023
4,22.0,Hair disorder,3,16173023
0,22.0,Alopecia,6,16173028
1,22.0,Hair texture abnormal,6,16173028
2,22.0,Hair disorder,6,16173028
3,22.0,Madarosis,6,16173028
4,22.0,Hair colour changes,6,16173028
0,22.0,IgA nephropathy,2,16173046
0,22.0,Myoclonus,2,16173054
0,22.0,Terminal state,6,16173086
0,22.0,Small intestinal perforation,5,16173102
0,22.0,Mucosal inflammation,6,16173137
0,22.0,Death,5,16173146
0,22.0,Cerebral haemorrhage,2,16173149
0,22.1,Nausea,6,16173159
1,22.1,Decreased appetite,6,16173159
2,22.1,Cough,6,16173159
3,22.1,Pain,6,16173159
4,22.1,Neutropenia,1,16173159
5,22.1,Breast cancer recurrent,6,16173159
6,22.1,General physical health deterioration,6,16173159
7,22.1,Bronchitis,1,16173159
8,22.1,Diarrhoea,6,16173159
9,22.1,Interstitial lung disease,6,16173159
10,22.1,Pneumonia,6,16173159
11,22.1,Dyspnoea,6,16173159
12,22.1,Vulvovaginal mycotic infection,6,16173159
13,22.1,Influenza,2,16173159
14,22.1,Pyrexia,6,16173159
15,22.1,Pleural effusion,6,16173159
16,22.1,Rhonchi,6,16173159
17,22.1,Asthenia,3,16173159
18,22.1,Candida infection,6,16173159
0,22.0,Disease progression,,16173171
1,22.0,Drug ineffective,,16173171
0,22.0,Vomiting,1,16173172
1,22.0,Diarrhoea,1,16173172
0,22.0,Infection,,16173178
0,22.0,Oxygen saturation decreased,2,16173191
1,22.0,Feeling hot,2,16173191
2,22.0,Malaise,2,16173191
3,22.0,Respiratory acidosis,2,16173191
4,22.0,Hypotension,2,16173191
0,22.0,Tachyarrhythmia,1,16173195
0,22.0,"Hallucination, visual",1,16173208
0,22.0,Malignant neoplasm progression,6,16173234
1,22.0,Skin reaction,3,16173234
2,22.0,Pruritus,3,16173234
0,22.0,Bladder cancer,1,16173285
0,22.0,Death,5,16173341
1,22.0,Drug resistance,6,16173341
0,22.0,Metastases to bone,6,16173392
0,22.0,Adverse event,6,16173451
1,22.0,Transfusion,6,16173451
2,22.0,Inappropriate schedule of product administration,6,16173451
3,22.0,Transfusion,6,16173451
4,22.0,Adverse event,6,16173451
5,22.0,Product use in unapproved indication,6,16173451
6,22.0,Inappropriate schedule of product administration,6,16173451
0,22.0,Neoplasm progression,6,16173455
0,22.0,Asthenia,,16173456
1,22.0,Diarrhoea,,16173456
2,22.0,Nausea,,16173456
0,22.0,Stomatitis,,16173463
0,22.1,Bacterial sepsis,1,16173467
1,22.1,Gastroenteritis,1,16173467
2,22.1,Adverse drug reaction,1,16173467
3,22.1,Myocardial infarction,1,16173467
0,22.0,Disease progression,,16173480
0,22.0,Death,,16173489
0,22.0,Stent placement,,16173532
0,22.0,Therapy cessation,,16173563
1,22.0,Blood count abnormal,,16173563
0,22.0,Dyspnoea,6,16173597
0,22.0,Endometriosis,6,16173600
1,22.0,Metastases to central nervous system,6,16173600
2,22.0,Oestradiol abnormal,6,16173600
0,22.0,Lumbar vertebral fracture,1,16173604
1,22.0,Fall,6,16173604
2,22.0,Fatigue,3,16173604
3,22.0,Intervertebral disc disorder,1,16173604
4,22.0,Spinal pain,2,16173604
0,22.0,Adverse drug reaction,,16173638
0,22.0,Insomnia,6,16173672
1,22.0,Tinnitus,6,16173672
2,22.0,Neoplasm malignant,6,16173672
0,22.0,Decreased appetite,,16173677
0,22.0,Toxicity to various agents,,16173702
1,22.0,Hypophagia,,16173702
2,22.0,Stomatitis,,16173702
0,22.0,Febrile neutropenia,6,16173703
1,22.0,Mucosal disorder,6,16173703
2,22.0,Stomal hernia,6,16173703
3,22.0,Ulcer,2,16173703
0,22.0,Groin pain,,16173714
0,22.0,Bacterial infection,3,16173735
1,22.0,Arthropathy,6,16173735
0,22.0,Pulmonary mass,6,16173749
0,22.0,Mean cell volume increased,6,16173788
1,22.0,Blood sodium decreased,2,16173788
2,22.0,Eosinophil count decreased,6,16173788
3,22.0,Haemoglobin decreased,6,16173788
4,22.0,Urinary tract infection,6,16173788
5,22.0,Metastases to bone,6,16173788
6,22.0,White blood cell count decreased,6,16173788
7,22.0,Constipation,2,16173788
8,22.0,Hypercalcaemia,6,16173788
9,22.0,Metastases to liver,6,16173788
10,22.0,Liver function test abnormal,6,16173788
11,22.0,Malignant neoplasm progression,6,16173788
12,22.0,General physical health deterioration,6,16173788
13,22.0,Blood potassium decreased,6,16173788
14,22.0,Vomiting,2,16173788
15,22.0,Oral pain,6,16173788
16,22.0,Spinal fracture,6,16173788
17,22.0,Malaise,2,16173788
18,22.0,Diarrhoea,6,16173788
19,22.0,Lethargy,2,16173788
20,22.0,Chest pain,2,16173788
21,22.0,Hypocalcaemia,6,16173788
22,22.0,Decreased appetite,2,16173788
23,22.0,Platelet count decreased,6,16173788
24,22.0,Skin infection,1,16173788
25,22.0,Neutropenia,6,16173788
26,22.0,Lower respiratory tract infection,6,16173788
27,22.0,Nausea,2,16173788
28,22.0,Red blood cell count decreased,6,16173788
0,22.0,Pneumonia,1,16173792
0,22.1,Autoimmune haemolytic anaemia,1,16173841
0,22.0,Death,5,16173879
1,22.0,Neoplasm progression,6,16173879
0,22.0,Death,5,16173888
0,22.0,Cholangitis,6,16173889
0,22.0,Asthenia,2,16173896
1,22.0,White blood cell count decreased,3,16173896
2,22.0,Abdominal pain upper,3,16173896
3,22.0,Diarrhoea,3,16173896
4,22.0,Fatigue,6,16173896
5,22.0,Orthostatic hypotension,3,16173896
6,22.0,Red blood cell count decreased,6,16173896
0,22.0,Interstitial lung disease,1,16173911
0,22.0,Death,5,16173912
0,22.0,Constipation,6,16173972
1,22.0,Flatulence,6,16173972
2,22.0,Product dose omission,6,16173972
3,22.0,Decreased appetite,6,16173972
0,22.0,Peritonitis,6,16174003
1,22.0,Renal infarct,6,16174003
2,22.0,Diarrhoea,6,16174003
3,22.0,Intra-abdominal fluid collection,6,16174003
4,22.0,Splenic infarction,6,16174003
5,22.0,Abdominal discomfort,6,16174003
6,22.0,Autoimmune colitis,6,16174003
7,22.0,Infection,6,16174003
8,22.0,Malignant peritoneal neoplasm,6,16174003
9,22.0,Blood urine present,6,16174003
10,22.0,Peritoneal neoplasm,6,16174003
11,22.0,Dysuria,6,16174003
0,22.0,Systemic inflammatory response syndrome,1,16174024
1,22.0,Carbohydrate antigen 125 increased,6,16174024
2,22.0,Lymphadenopathy,2,16174024
3,22.0,C-reactive protein increased,6,16174024
0,22.0,Metastases to bone,6,16174026
1,22.0,Drug ineffective,6,16174026
0,22.0,Arterial rupture,5,16174067
0,22.0,Fatigue,,16174077
0,22.0,Malignant neoplasm progression,6,16174106
1,22.0,Deep vein thrombosis,6,16174106
2,22.0,Therapy partial responder,6,16174106
0,22.0,Death,,16174183
0,22.0,Electrocardiogram QT prolonged,6,16174299
0,22.0,Febrile neutropenia,1,16174315
0,22.0,Inappropriate schedule of product administration,6,16174421
1,22.0,Haemorrhage,1,16174421
0,22.1,Gastrointestinal toxicity,3,16174432
1,22.1,Disease progression,6,16174432
2,22.1,Hypertension,2,16174432
3,22.1,PIK3CA-activated mutation,6,16174432
4,22.1,Carcinoembryonic antigen increased,2,16174432
5,22.1,Metastases to liver,6,16174432
6,22.1,Hepatic necrosis,6,16174432
7,22.1,Carbohydrate antigen 19-9 increased,2,16174432
8,22.1,Rash pustular,6,16174432
0,22.0,Fungal infection,2,16174438
0,22.0,Epistaxis,1,16174442
1,22.0,Rhinorrhoea,1,16174442
2,22.0,Fatigue,2,16174442
3,22.0,Taste disorder,6,16174442
4,22.0,Weight increased,6,16174442
5,22.0,Leukopenia,3,16174442
6,22.0,Hypokalaemia,1,16174442
7,22.0,Increased appetite,6,16174442
8,22.0,Diarrhoea,6,16174442
9,22.0,Insomnia,1,16174442
0,22.0,Deafness,3,16174444
1,22.0,Blindness,3,16174444
0,22.1,Respiratory disorder,5,16174466
1,22.1,Fatigue,3,16174466
2,22.1,Pneumocystis jirovecii pneumonia,5,16174466
0,22.0,Dermatitis acneiform,1,16174511
0,22.1,Paraesthesia,6,16174527
1,22.1,Oral candidiasis,6,16174527
2,22.1,Renal failure,6,16174527
3,22.1,Thrombocytopenia,6,16174527
0,22.0,Fatigue,1,16174545
1,22.0,Hypertension,6,16174545
2,22.0,Neutropenia,6,16174545
3,22.0,Abdominal pain,6,16174545
4,22.0,Pain in jaw,6,16174545
5,22.0,Clostridium difficile colitis,6,16174545
6,22.0,Decreased appetite,1,16174545
7,22.0,Diarrhoea,6,16174545
0,22.0,Respiratory failure,1,16174549
1,22.0,Bronchospasm,1,16174549
0,22.0,Haemoglobin decreased,6,16174550
1,22.0,Bone marrow failure,6,16174550
0,22.1,Weight increased,2,16174570
0,22.0,Peripheral nerve injury,3,16174638
1,22.0,Nervousness,3,16174638
2,22.0,Biliary colic,6,16174638
3,22.0,Hot flush,6,16174638
4,22.0,Pain in extremity,3,16174638
5,22.0,Constipation,6,16174638
6,22.0,Somnolence,6,16174638
7,22.0,Abdominal pain upper,6,16174638
8,22.0,Lacrimation increased,6,16174638
9,22.0,Fatigue,6,16174638
10,22.0,Irritable bowel syndrome,6,16174638
11,22.0,Nausea,3,16174638
12,22.0,Asthenia,3,16174638
13,22.0,Nasopharyngitis,6,16174638
14,22.0,Feeling abnormal,6,16174638
15,22.0,Anxiety,6,16174638
16,22.0,Restless legs syndrome,6,16174638
17,22.0,Dizziness,6,16174638
18,22.0,Gastrointestinal disorder,6,16174638
19,22.0,Pruritus,6,16174638
0,22.0,General physical health deterioration,5,16174681
0,22.0,Death,5,16174701
0,22.0,Drug intolerance,3,16174713
1,22.0,Fatigue,,16174713
2,22.0,Pain in extremity,2,16174713
3,22.0,Insomnia,,16174713
4,22.0,Gait disturbance,3,16174713
5,22.0,Fatigue,,16174713
6,22.0,Neuropathy peripheral,3,16174713
7,22.0,Drug ineffective,3,16174713
8,22.0,Neuropathy peripheral,3,16174713
9,22.0,Pain,,16174713
10,22.0,Musculoskeletal pain,2,16174713
0,22.0,Stomatitis,2,16174743
1,22.0,Dizziness,3,16174743
2,22.0,Aphthous ulcer,1,16174743
3,22.0,Lip swelling,2,16174743
4,22.0,Tooth fracture,6,16174743
0,22.0,Febrile neutropenia,6,16174745
1,22.0,Mucosal ulceration,2,16174745
0,22.0,Bone marrow failure,2,16174753
0,22.0,Neoplasm progression,3,16174781
1,22.0,Drug ineffective,3,16174781
0,22.0,Diarrhoea,,16174785
1,22.0,Asthenia,,16174785
0,22.0,Neuropathy peripheral,3,16174791
1,22.0,Fatigue,,16174791
2,22.0,Off label use,,16174791
0,22.0,Neurotoxicity,1,16174831
0,22.0,Malignant neoplasm progression,5,16174881
0,22.0,Pain in extremity,1,16174956
1,22.0,Constipation,1,16174956
2,22.0,Expired product administered,1,16174956
0,22.0,Diarrhoea,6,16175067
1,22.0,Taste disorder,6,16175067
2,22.0,Acne,6,16175067
0,22.0,Anaemia,6,16175085
0,22.0,Hepatitis chronic active,,16175096
1,22.0,Hepatitis B,,16175096
2,22.0,Decreased appetite,1,16175096
3,22.0,Hepatic function abnormal,2,16175096
4,22.0,Vomiting,1,16175096
5,22.0,Fatigue,1,16175096
0,22.0,Pancreatic enlargement,1,16175124
1,22.0,Polyarthritis,1,16175124
2,22.0,Amylase increased,1,16175124
3,22.0,Lipase increased,1,16175124
0,22.0,Angina pectoris,1,16175153
1,22.0,Neutrophil count decreased,3,16175153
2,22.0,Hepatic function abnormal,3,16175153
0,22.0,Headache,1,16175172
1,22.0,Sleep disorder,1,16175172
2,22.0,Arthralgia,1,16175172
0,22.0,Cellulitis,6,16175184
1,22.0,Dyspnoea,5,16175184
2,22.0,Pyrexia,6,16175184
3,22.0,Anaemia,6,16175184
4,22.0,Inflammation,6,16175184
0,22.0,Dizziness,1,16175212
1,22.0,Spinal laminectomy,6,16175212
2,22.0,Prostate cancer metastatic,3,16175212
3,22.0,Monoplegia,6,16175212
4,22.0,Muscular weakness,6,16175212
5,22.0,Headache,1,16175212
0,22.0,Death,5,16175215
0,22.0,Alopecia,6,16175226
0,22.1,Mechanical ileus,1,16175250
0,22.0,Hot flush,6,16175261
1,22.0,Tuberculosis,6,16175261
2,22.0,Hyperhidrosis,6,16175261
3,22.0,Crohn^s disease,6,16175261
0,22.0,Pleural effusion,2,16175496
0,22.0,Diarrhoea,1,16175497
1,22.0,Nausea,1,16175497
2,22.0,Malaise,1,16175497
3,22.0,Vomiting,1,16175497
4,22.0,Pain,6,16175497
0,22.0,Device related infection,2,16175514
0,22.0,Nausea,1,16175525
1,22.0,Vomiting,1,16175525
2,22.0,Abdominal discomfort,2,16175525
3,22.0,Asthenia,2,16175525
0,22.0,Anaemia,6,16175568
1,22.0,Tumour haemorrhage,6,16175568
0,22.0,Asthenia,6,16175589
1,22.0,Fatigue,6,16175589
2,22.0,Seasonal allergy,2,16175589
0,22.0,Tumour haemorrhage,1,16175593
1,22.0,Arterial haemorrhage,1,16175593
2,22.0,Malignant neoplasm progression,6,16175593
3,22.0,Shock,1,16175593
0,22.0,Myocardial infarction,2,16175607
0,22.0,Death,5,16175613
0,22.0,Death,5,16175614
0,22.0,Death,5,16175617
0,22.0,Behaviour disorder,6,16175618
0,22.0,Infection,6,16175619
0,22.0,Body surface area decreased,6,16175649
1,22.0,Neutropenia,6,16175649
2,22.0,Renal impairment,3,16175649
3,22.0,Pain,1,16175649
4,22.0,Haemoglobin decreased,3,16175649
5,22.0,Asthenia,3,16175649
6,22.0,Full blood count decreased,6,16175649
7,22.0,Malaise,6,16175649
8,22.0,Fatigue,3,16175649
9,22.0,Weight decreased,6,16175649
10,22.0,Abdominal pain,1,16175649
0,22.0,Pulmonary embolism,6,16175713
0,22.0,Blood magnesium decreased,1,16175714
1,22.0,Atrial fibrillation,1,16175714
2,22.0,Diarrhoea,1,16175714
0,22.0,Interstitial lung disease,6,16175715
0,22.0,Atrial fibrillation,1,16175716
1,22.0,Diarrhoea,1,16175716
0,22.0,Osteonecrosis of jaw,6,16175717
0,22.0,Renal failure,3,16175730
1,22.0,Tubulointerstitial nephritis,3,16175730
2,22.0,Chronic kidney disease,3,16175730
0,22.0,Acute myocardial infarction,1,16175758
1,22.0,Electrocardiogram abnormal,1,16175758
0,22.0,Bone marrow failure,6,16175775
1,22.0,Gastrointestinal disorder,6,16175775
0,22.0,Neoplasm progression,6,16175808
0,22.0,Necrosis,6,16175831
1,22.0,Internal haemorrhage,6,16175831
0,22.0,Pneumonia,6,16175878
1,22.0,Sepsis,6,16175878
2,22.0,Therapeutic procedure,6,16175878
0,22.1,Product use in unapproved indication,6,16175879
1,22.1,Acute hepatic failure,5,16175879
2,22.1,Metastases to bone,6,16175879
3,22.1,Off label use,6,16175879
4,22.1,Septic shock,5,16175879
5,22.1,Metastases to lymph nodes,6,16175879
0,22.0,Pericardial effusion,2,16175898
1,22.0,Respiratory failure,2,16175898
2,22.0,Confusional state,2,16175898
3,22.0,Hypercalcaemia,2,16175898
4,22.0,Sepsis,2,16175898
5,22.0,Left ventricular dysfunction,6,16175898
6,22.0,Pneumonia,2,16175898
7,22.0,Acute kidney injury,2,16175898
0,22.0,White blood cell count decreased,6,16175906
0,22.0,Headache,1,16175914
1,22.0,Atrial fibrillation,1,16175914
2,22.0,Hyperhidrosis,1,16175914
0,22.1,Muscular weakness,2,16175916
1,22.1,Pneumonia,1,16175916
2,22.1,Dyspnoea,1,16175916
0,22.0,Rash,1,16176015
1,22.0,Malignant neoplasm progression,6,16176015
0,22.0,Drug ineffective,6,16176043
0,22.0,Neurotoxicity,1,16176049
0,22.1,Heart rate increased,6,16176060
1,22.1,Diarrhoea,6,16176060
2,22.1,Vomiting,6,16176060
3,22.1,Blood pressure increased,6,16176060
4,22.1,Product dose omission,6,16176060
0,22.0,Polyneuropathy,1,16176080
0,22.0,Mucosal inflammation,1,16176090
1,22.0,Dermatitis,1,16176090
2,22.0,Thrombocytopenia,1,16176090
0,22.0,Rash erythematous,2,16176102
0,22.0,Cardiac failure congestive,5,16176103
0,22.0,Decreased appetite,6,16176107
1,22.0,Skin ulcer,6,16176107
2,22.0,Somnolence,6,16176107
0,22.1,Hyponatraemia,1,16176123
1,22.1,Polyneuropathy,2,16176123
2,22.1,Oedema peripheral,1,16176123
3,22.1,Nausea,3,16176123
4,22.1,Pyrexia,1,16176123
5,22.1,Nasopharyngitis,1,16176123
6,22.1,Fatigue,3,16176123
7,22.1,Anaemia,3,16176123
8,22.1,Leukopenia,1,16176123
9,22.1,Transaminases increased,1,16176123
0,22.0,Alopecia,2,16176159
0,22.0,Alopecia,3,16176162
0,22.0,Alopecia,2,16176202
0,22.0,Psychological trauma,6,16176203
1,22.0,Alopecia,2,16176203
0,22.0,Alopecia,3,16176206
0,22.0,Alopecia,2,16176208
1,22.0,Psychological trauma,6,16176208
0,22.0,Alopecia,2,16176213
1,22.0,Psychological trauma,6,16176213
0,22.1,Alopecia,2,16176242
0,22.0,Adverse reaction,,16176275
1,22.0,Death,5,16176275
0,22.0,Vomiting,1,16176306
1,22.0,Malaise,1,16176306
2,22.0,Weight increased,3,16176306
3,22.0,Alopecia,3,16176306
4,22.0,Neoplasm progression,6,16176306
0,22.0,White blood cell count decreased,6,16176449
0,22.0,Muscular weakness,2,16176455
1,22.0,Hypoaesthesia,2,16176455
0,22.0,Intestinal obstruction,3,16176459
0,22.0,Haemorrhage urinary tract,6,16176461
1,22.0,Product dose omission,6,16176461
2,22.0,Device difficult to use,6,16176461
0,22.1,Interstitial lung disease,5,16176469
1,22.1,Lung disorder,3,16176469
0,22.0,Blood potassium decreased,2,16176471
1,22.0,Renal tubular dysfunction,6,16176471
2,22.0,Resting tremor,6,16176471
3,22.0,Hypomagnesaemia,3,16176471
4,22.0,Blood calcium decreased,2,16176471
5,22.0,Blood phosphorus decreased,2,16176471
6,22.0,Orthostatic hypotension,6,16176471
0,22.0,Radiation pneumonitis,2,16176473
0,22.0,Memory impairment,6,16176476
1,22.0,Chills,6,16176476
2,22.0,Fatigue,2,16176476
3,22.0,Incorrect dose administered,3,16176476
4,22.0,Dizziness,6,16176476
5,22.0,Circadian rhythm sleep disorder,3,16176476
6,22.0,Night sweats,6,16176476
7,22.0,Abdominal pain upper,6,16176476
8,22.0,Neck pain,6,16176476
9,22.0,Treatment noncompliance,3,16176476
10,22.0,Pain,6,16176476
11,22.0,Back pain,6,16176476
12,22.0,Nausea,2,16176476
13,22.0,Headache,6,16176476
14,22.0,Product storage error,6,16176476
15,22.0,Off label use,1,16176476
16,22.0,Red blood cell count decreased,6,16176476
17,22.0,Haematocrit decreased,6,16176476
0,22.0,Eye inflammation,3,16176487
0,22.0,Malaise,1,16176514
1,22.0,Body temperature decreased,1,16176514
2,22.0,Blood magnesium decreased,1,16176514
0,22.0,Sinusitis,1,16176547
1,22.0,Musculoskeletal pain,1,16176547
2,22.0,Skin infection,1,16176547
3,22.0,Neck pain,1,16176547
4,22.0,Hypoaesthesia,3,16176547
5,22.0,Pain in extremity,1,16176547
6,22.0,Pneumonia,5,16176547
0,22.0,Oral cavity fistula,3,16176553
1,22.0,Osteonecrosis of jaw,3,16176553
0,22.0,Skin exfoliation,3,16176579
1,22.0,Epistaxis,3,16176579
2,22.0,Nervousness,3,16176579
3,22.0,Generalised erythema,3,16176579
4,22.0,Pruritus generalised,3,16176579
5,22.0,Skin mass,3,16176579
0,22.0,Death,5,16176582
0,22.0,Toothache,3,16176583
1,22.0,Tooth disorder,3,16176583
0,22.0,Neoplasm malignant,6,16176628
1,22.0,Abdominal distension,6,16176628
0,22.0,Hepatotoxicity,5,16176638
0,22.0,Product dose omission,6,16176649
1,22.0,No adverse event,6,16176649
0,22.0,Oral pain,6,16176659
1,22.0,Decreased appetite,4,16176659
2,22.0,Vomiting,6,16176659
3,22.0,Musculoskeletal pain,6,16176659
0,22.0,Neoplasm progression,6,16176725
0,22.1,Malignant neoplasm progression,5,16176771
1,22.1,Interstitial lung disease,5,16176771
0,22.0,Angiodermatitis,4,16176782
1,22.0,Skin necrosis,4,16176782
0,22.0,Rash,3,16176789
0,22.1,Anaemia,4,16176804
1,22.1,Acute kidney injury,4,16176804
0,22.0,Rash pruritic,6,16176819
1,22.0,Dry skin,6,16176819
2,22.0,Malignant neoplasm progression,6,16176819
3,22.0,Oropharyngeal discomfort,6,16176819
4,22.0,Erythema,6,16176819
5,22.0,Oropharyngeal blistering,6,16176819
6,22.0,Rash,6,16176819
7,22.0,Adrenal insufficiency,6,16176819
8,22.0,Glossodynia,6,16176819
9,22.0,Blood pressure increased,6,16176819
10,22.0,Speech disorder,6,16176819
11,22.0,Diarrhoea,6,16176819
12,22.0,Nodule,6,16176819
13,22.0,Oral pain,6,16176819
14,22.0,Hypothyroidism,6,16176819
15,22.0,Transaminases increased,6,16176819
0,22.0,Alopecia,3,16176820
1,22.0,Discomfort,6,16176820
2,22.0,Emotional distress,6,16176820
3,22.0,Pain,6,16176820
4,22.0,Injury,6,16176820
5,22.0,Anhedonia,6,16176820
6,22.0,Anxiety,6,16176820
0,22.0,Stress cardiomyopathy,6,16176826
0,22.0,Incision site erythema,3,16176827
1,22.0,Ascites,3,16176827
2,22.0,Incision site oedema,3,16176827
0,22.0,Cerebral haemorrhage,2,16176890
0,22.0,Extrasystoles,2,16176919
1,22.0,Tachycardia,2,16176919
2,22.0,Leukopenia,2,16176919
3,22.0,Dyspnoea,2,16176919
0,22.0,Visual impairment,6,16176946
1,22.0,Economic problem,6,16176946
2,22.0,Inappropriate schedule of product administration,6,16176946
3,22.0,Fatigue,6,16176946
4,22.0,Vomiting,6,16176946
0,22.0,Urinary tract infection,6,16176954
1,22.0,Gait disturbance,3,16176954
2,22.0,Haemorrhage,6,16176954
3,22.0,Throat tightness,3,16176954
4,22.0,Hospitalisation,6,16176954
5,22.0,Pain in extremity,3,16176954
6,22.0,Anaemia,6,16176954
7,22.0,Rash,3,16176954
8,22.0,Vomiting,3,16176954
9,22.0,Gastrointestinal stoma complication,3,16176954
10,22.0,Death,5,16176954
0,22.0,Radiation pneumonitis,2,16176981
1,22.0,Subcutaneous emphysema,2,16176981
2,22.0,Pneumomediastinum,2,16176981
0,22.0,Hypersensitivity vasculitis,1,16177037
0,22.0,Pneumonia aspiration,5,16177076
1,22.0,Emphysematous pyelonephritis,2,16177076
2,22.0,Candida infection,2,16177076
0,22.0,Metastases to bone,6,16177083
0,22.0,Erythema,6,16177101
1,22.0,Ejection fraction decreased,6,16177101
2,22.0,Polyneuropathy,6,16177101
3,22.0,Pruritus,1,16177101
4,22.0,Metastases to liver,6,16177101
5,22.0,Pruritus,1,16177101
6,22.0,Peripheral swelling,6,16177101
7,22.0,Hepatomegaly,6,16177101
8,22.0,Hypoaesthesia,6,16177101
9,22.0,Oedema peripheral,6,16177101
10,22.0,Metastases to lung,6,16177101
0,22.0,Haemorrhagic stroke,1,16177129
1,22.0,Pain in extremity,1,16177129
2,22.0,Haemorrhage,1,16177129
0,22.0,Incorrect route of product administration,6,16177134
1,22.0,Injection site swelling,6,16177134
2,22.0,Injection site pain,6,16177134
0,22.0,Drug dose omission by device,6,16177170
1,22.0,Device failure,6,16177170
2,22.0,Neutrophil count decreased,1,16177170
